Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2013 | 01-2013 | 12-2012 | 04-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -2,050 | -2,050 | N/A |
| Depreciation Amortization | 20 | 30 | 30 | 30 |
| Other Working Capital | 460 | 30 | 30 | 30 |
| Other Operating Activity | 330 | 160 | 160 | 140 |
| Operating Cash Flow | $810 | $-1,830 | $-1,830 | $200 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -10 | -90 | -90 | -90 |
| Investing Cash Flow | $-10 | $-90 | $-90 | $-90 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 6,400 | 5,560 | 5,560 | 5,570 |
| Financing Cash Flow | $6,400 | $5,560 | $5,560 | $5,570 |
| Beginning Cash Position | N/A | 4,600 | 4,600 | N/A |
| End Cash Position | N/A | 8,240 | 8,240 | N/A |
| Net Cash Flow | $7,200 | $3,630 | $3,630 | $5,680 |
| Free Cash Flow | ||||
| Operating Cash Flow | 810 | -1,830 | -1,830 | 200 |
| Free Cash Flow | 810 | -1,830 | -1,830 | 200 |